Background: Axillary implant location is an alternative implant location in patients for cardiac
BACKGROUND
Pacemakers and internal cardioverters/defibrillators (ICDs) are widely accepted therapies in the pediatric population. These devices are generally referred to cardiac implantable electronic devices (CIEDs). The standard transvenous implant location is via an infraclavicular incision, typically in the left chest. This approach may produce a significant scar that tends to spread with healing and may be raised or appears red. In addition, the contour of the device may be readily evident and these cosmetic changes may affect health-related quality of life (HRQOL), especially in young patients who are concerned about their body image. While alternative cardiac device implant locations have been suggested, they did not appear to be widely adopted. 1, 2 It is known that pediatric patients with chronic medical conditions have lower HRQOL when compared to healthy controls. [3] [4] [5] [6] Patients with CIEDs have significantly lower HRQOL compared to patients with mild congenital heart disease (CHD) and healthy controls. [7] [8] [9] [10] [11] While it could be suspected that lower HRQOL would be related to factors, such as device shocks, lifestyle modifications, or activity restrictions associated with underlying cardiac disease, these factors were not associated with QOL in a prior report. 8 To our knowledge, no prior manuscript has specifically evaluated surgical scar appearance or location of the scar as possibly affecting QOL in pediatric pacemaker and ICD populations. Cardiac rhythm devices are being implanted in children with increased frequency. 12, 13 Improving cosmetic outcomes from surgical scars may impact HRQOL and decrease the impact of disease. 2 The axillary implant location is the most commonly used alternative approach for CIED implantation. With this approach, there are either no scars or only a small scar on the patient's chest, with the larger device scar being hidden in the axilla. 14 The purpose of this multicenter investigation was to compare HRQOL and patient perceptions of surgical scar comparing two different implant locations (infraclavicular vs axillary) among children with a CIED.
METHODS

Research design
This is a cross-sectional, multi-institutional study from eight tertiary 
Population
Demographic information (including self-reported ethnicity) was collected through parent report. Clinical information was collected through chart review. The primary diagnosis was that which resulted in CIED implantation.
Patients were eligible for enrollment if they were able to speak English, they were of age 8-18 years, and had a transvenous CIED.
Patients were excluded if they had complex CHD, a prior sternotomy (including an epicardial CIED), thoracotomy or other significant scarring not caused by transvenous CIED implantation, implantation in the preceding 3 months, significant life events within the preceding 6 months (eg, serious illness [personal or family], death of family or friends, divorce/separation, or discharge of defibrillator), significant comorbid disease, or a diagnosed developmental delay that prohibited them from being able to complete the patient forms.
Our patient population was also compared to a healthy control population similarly to as reported in a previously published study. 8 This healthy control population was obtained from the initial PedsQL psychometric article and the PedsQL data from within the Pediatric Cardiac Quality of Life inventory (PCQLI) Validation Study. 6 
Implantation procedure
Patients were analyzed based on CIED implant location type (infraclavicular vs axillary). Patients in the infraclavicular group had implantation of their CIED with a standard approach of a single incision in the infraclavicular area and the device implanted either in prepectoral or submuscular pocket. 14 Implantation of an axillary device was performed by using two different techniques. 1, 15 The first technique involves making a small infraclavicular incision for lead placement and an axillary incision for placement of the device. 1 The second technique involves accessing the axillary vein, followed by making a 4-6-cm incision along the posterolateral margin of the pectoralis major muscle, 15 or making an incision along the anterior axillary line with the device placed in the anterior chest under the pectoralis muscle.
Examples of the surgical scarring resulting from CIED procedures are presented in Figure 1 . It is important to note that the decision with respect to device location or implant technique was determined by the patient and the physician at the implanting center. Patients included in this study had their devices implanted for >3 months prior to be asked to fill out questionnaires. Patients were therefore not randomized to device location. Also of note is that some implanting centers would utilize only one technique or would offer both. There was no specific date at which a center changed from one technique to the other.
Testing inventory
Patient scar assessment questionnaire (PSAQ)
The PSAQ (validated in adults) was used by patients to convey an opinion of their linear scar. 2 Adolescents (13-18 years) were asked to evaluate the scar on five domains: appearance, symptoms, consciousness, and satisfaction with appearance, and satisfaction with symptoms. Each domain is evaluated independently. A higher score reflects a poorer perception of the scar related to the domain being evaluated.
Quality of life assessments
Patient-parent pairs completed the generic Pediatric QOL Inventory (PedsQL) to assess patient and parent-proxy HRQOL. The PedsQL generates a Total score, and Physical Health Summary and Psychological Health Summary subscale scores. The Psychological Health Summary score is a composite of emotional, social, and school functioning. 16 Using existing published data on normal patients, the PedsQL data generated by patients and parents from this study were compared to those of healthy children. 3 The maximum score for the PedsQL Total, Physical and Psychological Health Summary, and Psychosocial Health Summary subscale scores is 100. Children and adolescents also completed the Self-Perception Profile for Children (SPPC) and Self-Perception Profile for Adolescents (SPPA), respectively. [17] [18] [19] In the QOL study of cardiac devices in pediatrics by Czosek et al. 8 ,
having an implantable cardiac device was associated with lower QOL inventory scoring. The authors report that key drivers of patient QOL were the presence of an ICD and CHD. For patients, selfperception was a key driver and for parents, behavioral issues were a concern. Multivariable linear models for the total PedsQL score, the difference between patient and parent PedsQL scores and PSAQ scores were used to test for an interaction between type of device and location of device. We considered seven variables as potential confounders in our multivariable models: age at first diagnosis, duration of device/time with scar, sex, race (white vs other), income (<50 000, 50-100 000, and >100 000), cardiac diagnosis (normal heart structure, cardiomyopathy, and CHD) and participation in independent education plans. Variables were included in the final model if they were significantly associated with the outcome based on simple linear regression.
The significance was set at 0.05 and 0.017 for comparisons in PedsQL between the axillary, infraclavicular, and healthy control groups. For this comparison R version 3.1.1 software (R Foundation for Statistical
Computing, Vienna, Austria, http://www.R-project.org/) was used.
RESULTS
Patient demographics
One hundred and forty-one patients were enrolled in the study (2011) (2012) (2013) (2014) . Axillary devices were implanted in 55 (39%) and infraclavicular devices in 86 (61%) patients. A summary of device type and implant location by center (blinded) is shown in Figure 2 . Patient and parent demographics comparing the axillary versus infraclavicular implant location are presented in Table 1 and in Appendix Tables A and B for There was no significant difference between axillary and infraclavicular groups with respect to maternal education (P = 0.44) or family income (P = 0.46). There was no difference in the number of additional catheter-based or minimally invasive cardiac procedures unrelated to device or lead functionality (Appendix Table C ). Additional cardiac electrophysiologic procedures in both groups included generator change, lead revisions, and device relocation.
Patient scar assessment questionnaire
All four subscales were moderately to strongly correlated with their global assessment variables: appearance (rho = 0.6), consciousness (rho = 0.74), satisfaction with appearance (rho = 0.85), and
TA B L E 1 Demographics of patients comparing axillary and infraclavicular device implant location
Overall (n = 141) Axillary (n = 55) Infraclavicular (n = 86) P value was rated significantly more favorably in the axillary group relative to the infraclavicular group by 2 points (95% CI: −3, 0). There was no statistically significant difference in appearance or the satisfaction with symptoms between the two locations, after adjusting for device type. In the multivariable model, the difference between axillary and infraclavicular placement was not significantly different between the ICD and pacemaker groups (interaction P = 0.603). Based on the adjusted model (shown in Table 2 ), patients in the axillary group reported, on average, PedsQL Total scores were 6 points higher than the infraclavicular group.
Pediatric QOL Inventory (PedsQL)
In an unadjusted analysis, patients assessed their quality of life to be, on average, higher than their parents did (mean difference: 4.8, 95% CI: 2, 7.5) (P = 0.001). Race and cardiac diagnosis were significantly associated with the difference in score between patients and parent-proxy reporters. In an adjusted model assessing for the difference in PedsQL Total score between patients and parent-proxy reporters, the interaction between device type and location was not significant (P = 0.5). In the final multivariable model, there was no difference between patient and parent-proxy reported PedsQL Total score between the axillary and infraclavicular groups (P = 0.2).
In comparison to healthy controls, device patients and parent-proxy reports had lower HRQOL regardless of device location (Figure 4 ). Figure 5 shows ICD patients compared to healthy controls. Figure 6 shows axillary patients compared to healthy controls. 
TA B L E 2 Univariate and multivariable predictors of PedsQL
SPPC and SPPA
None of the SPPS or SPPA subscale scores were significantly different between the axillary and infraclavicular groups (Appendix Tables D, E, and F).
DISCUSSION
This was a multicenter study evaluating patient scar perception and QOL in children with a CIED. To our knowledge, this is the first study comparing device implant location and cosmetic outcomes in children.
It is challenging to attempt to quantify a patient's perception of their scar and of their perception of their CIED in general, as perhaps separate from their underlying disease state. With the PSAQ, the patients evaluate their scars on appearance, symptoms, consciousness, satisfaction with appearance, and satisfaction with symptoms. In our study, we show that patient scar perception appears to be impacted by variables of time with a scar, race, device type, and family income. In moving from simple scar perception and appearance, our study further evaluated quality of life with the PedsQL score. Based on the adjusted model, patients in the axillary group reported, on average, PedsQL Total scores were 6 points higher than the infraclavicular group (95% CI: 1.38, 10.82) (P = 0.01). This would suggest that axillary implant leads to a more favorable quality of life. In addition, similar to prior studies, 8 our patients with CIED scored significantly lower than healthy controls. Thus, simply having a CIED negatively affected patient assessment of their quality of life. Interestingly, in an unadjusted analysis, patients reported a higher quality of life than their parents, although this difference was no longer seen in the adjusted analyses. Opportunities, therefore, exist to improve cosmesis and quality of life scores in children who have undergone implantation of a lifesaving CIEDs.
Czosek et al reported the impact of cardiac devices on the quality of life in pediatric patients. 8 Their main conclusions were that patients with CIEDs had a lower quality of life compared to healthy controls and patients with mild forms of CHD. 8 Key drivers were the presence of an ICD and CHD. The differences between our study and this prior study are that the patient population was much different. By study design, we excluded any patient with a prior sternotomy, which therefore excluded patients who had a prior epicardial pacemaker or repaired CHD. In Czosek's study, most of the pacemaker patients had epicardial systems, and a high percentage of the ICD patients had CHD.
Thus, a high percentage of their population had prior sternotomies.
While the axillary approach may provide improved QOL and patient scar perception, particularly for patients with an ICD, a recent multinational retrospective study compared the standard infraclavicular and axillary implant locations with respect to device functionality and complication rates. In this study, Rausch et al reported similar outcomes with regards to lead performance at implantation, procedural complication rates, device pocket infections, and need for reintervention. 14 Similarly, we show no differences in the number of additional cardiac electrophysiological procedures providing insight into wire and device characteristics. While the current study did not specifically investigate repeat procedures for device generator changes or lead revisions, the authors would like to provide a few insights. In our experience, the twoincisional axillary approach 14 that includes the leads being implanted in the standard infraclavicular area and then being tunneled to the axilla where the CIED is placed has similar ease of subsequent CIED surgery (such as generator change, lead extractions, etc.) compared to the standard infraclavicular approach. In the two-incisional axillary approach, the leads and the device are placed very near to the incision (1) the venous access site is at a more distal location and thus there is more length of lead to be addressed during lead extractions and (2) the device is placed "deep" and distant from the incision which makes locating the device more challenging during subsequent device surgeries.
Despite the similar device functionality and complication rate, one potential reason for the lack of utilization of the alternative axillary technique may be driven by concern for lead longevity with more lead exposed to external trauma, and decreased focus on cosmetic outcomes. In previous studies, clinicians have been found to perform poorly when asked to predict HRQOL in children with cardiac disease, 20 and that lack of understanding may have significant implications on their choice of implant location and interest in alternative implant techniques.
Similar to this data, prior studies in patients with cardiac devices have shown that those with an ICD generally have lower HRQOL for both the generic and disease-specific inventories when compared to pacemakers. 8, 9, 21 The pacemaker group was younger than the ICD group at initial implantation, and thus may be the reason there is less impact of the scar on HRQOL. It is possible that younger patients are less likely to be concerned with appearance and be used to the scar by adolescence, compared to the adolescent who has a new scar to adjust to.
While scar perception was demonstrated to be an important factor, it is unlikely to be the only mechanism affecting HRQOL. Specifically, poorer scar perception in the ICD group as a whole, and in the ICD infraclavicular group, but not in the pacemaker group, may be confounded by factors related to the disease necessitating implantation and the overall severity of the underlying disease process. In addition, based on the lack of difference in scores for the PSAQ satisfaction with symptoms subscale, it is unlikely that pain, is affecting scar perception.
The impact of scar appearance, consciousness, and satisfaction with appearance appear to play a much bigger role in scar perception. Furthermore, worse HRQOL in patients with an ICD may be confounded by potential for shock as well as additional activity-based restrictions. This is further suggested by the fact that the ICD group scored significantly lower in the physical domains and in the disease impact and psychosocial score in the PCQLI inventory. We attempted to control for disease severity and its impact on HRQOL by not including patients who had experienced a recent life-altering event. Importantly, though, there was no significant difference in the proportion of patients who had a device shock between the axillary and infraclavicular group.
This study has several important limitations. Factors related to lower scar perception in the ICD group could not be elucidated from this study. The reason for the lower scar perception of the axillary pacemaker group compared to the infraclavicular pacemaker group is unclear, and could not be assessed using selected study inventories.
Blinded review of scars could not be performed as many of the photographs obtained were of insufficient quality. We did not compare HRQOL between pacemakers and ICDs by device position due to small sample size in those specific groups. The PSAQ is validated in adults, and we used it in adolescents.
CONCLUSIONS
CIED implant location and type appear to have some effect on scar perception and quality of life as assessed by the PSAQ and HRQOL in both the generic and cardiac specific inventories, with the axillary group having better scar perception when compared to the infraclavicular group for the ICD group in particular. The axillary implant location can improve overall quality of life and can improve scar perception with the ICD device.
APPENDIX: 
